NCT04214275

Brief Summary

In this study, the effect of a pulmonary rehabilitation (PR) program on the respiratory function and quality of life of patients undergoing CABG surgery with an open-heart technique is examined. A randomized controlled experimental design was used. The study was conducted with two groups: the intervention group (n=25) and control group (n=25). The control group received standard care after CABG. In contrast, the experimental group, in addition to standard care, participated in a PR program created by the researchers. After CABG, the respiratory functions of both groups (clinical care day 4) and quality of life (6th week) evaluated

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 29, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 29, 2017

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

December 26, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 2, 2020

Completed
Last Updated

January 2, 2020

Status Verified

December 1, 2019

Enrollment Period

1.4 years

First QC Date

December 26, 2019

Last Update Submit

December 30, 2019

Conditions

Keywords

coronary artery bypasspulmonary rehabilitationquality of liferespiratory functions

Outcome Measures

Primary Outcomes (2)

  • The Pulmonary Function Test (PFT)

    A diagnostic criterion used to identify patients with or at risk of pulmonary dysfunction. The PFT assessment was performed using the NDD Easy on-PC spirometer. During this test, challenging expiratory volume (FEV1 % (\>80)), challenging vital capacity (FVC % (\>80)), FEV1/FVC ( %, \>80) ratio, and Peak Expiratory air pressure (PEF % (\>100)) were measured in the first second. The PFT was performed in the Chest Diseases Outpatient Clinic of the hospital preoperatively.

    Preoperative day

  • The Pulmonary Function Test (PFT) Change

    A diagnostic criterion used to identify patients with or at risk of pulmonary dysfunction. The PFT assessment was performed using the NDD Easy on-PC spirometer. During this test, challenging expiratory volume (FEV1 % (\>80)), challenging vital capacity (FVC % (\>80)), FEV1/FVC ( %, \>80) ratio, and Peak Expiratory air pressure (PEF % (\>100)) were measured in the first second. The PFT was performed in the Chest Diseases Outpatient Clinic of the hospital preoperatively. The PFT was performed in the Chest Diseases Outpatient Clinic of the 4th day of clinical care.

    4th day of clinical care

Secondary Outcomes (2)

  • The Short-Form Health Survey (SF-36)

    preoperative day

  • The Short-Form Health Survey (SF-36) Change

    postoperative sixth week

Study Arms (2)

intervention group

EXPERIMENTAL

standard care and participated in a pulmonary rehabilitation program

Other: pulmonary rehabilitation

control group

NO INTERVENTION

received standard care after coronary artery bypass graft

Interventions

Simple breathing techniques, secretion-removal techniques, airway-cleaning techniques, mobilization techniques and use of an incentive spirometer

intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who were extubated in twenty-four hours,
  • aged 18 or above,
  • had undergone CABG surgery using the open-heart method and using a saphenous vein graft for CABG,
  • who were conscious,
  • without visual and hearing problems,
  • who spoke Turkish,
  • had not orthopedic, psychiatric and neurological problems,
  • no co-morbid lung disease,
  • who had not been re-operated on,
  • had not postoperative cardiac dysfunction,
  • had not developed postoperative atrial fibrillation,
  • who were willing to participate in the study.

You may not qualify if:

  • Patients who were not extubated in twenty-four hours,
  • who were under 18 years of age,
  • had not undergone CABG surgery using the open-heart method and using a saphenous vein graft for CABG,
  • who were not conscious,
  • were visual and hearing problems,
  • who don't spoke Turkish,
  • had orthopedic, psychiatric and neurological problems,
  • co-morbid lung disease,
  • who had been re-operated on,
  • had postoperative cardiac dysfunction,
  • had developed postoperative atrial fibrillation,
  • who were not willing to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Afyonkarahisar Health Science University

Afyonkarahisar, Centre, 03200, Turkey (Türkiye)

Location

Study Officials

  • Yeliz Ciğerci, PhD

    +90 272 444 0304

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

December 26, 2019

First Posted

January 2, 2020

Study Start

August 1, 2016

Primary Completion

December 29, 2017

Study Completion

December 29, 2017

Last Updated

January 2, 2020

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will share

Locations